Results

Total Results: 6,952 records

Showing results for "weeks".

41. 122. Treatment Recommendations: Medications (Continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide122.html
    October 01, 2014 -       Bupropion SR 26 2.0 (1.8, 2.2) 24.2 (22.2, 26.4) Nicotine Patch (6-14 weeks … ) 32 1.9 (1.7, 2.2) 23.4 (21.3, 25.8) Long-Term Nicotine Patch (> 14 weeks) 10 1.9 (1.7 … (21.0, 26.6) Nortriptyline 5 1.8 (1.3, 2.6) 22.5 (16.8, 29.4) Nicotine Gum (6-14 weeks

42. Psn-Pdf (pdf file)
    psnet.ahrq.gov/node/49394/psn-pdf
    April 01, 2003 - At 42 weeks, she was admitted for post-dates labor induction using misoprostol and oxytocin. … ultrasound for serial growth if undelivered in 3 weeks. … Also, the mother usually feels the fetus move at approximately 16-20 weeks. … In the second trimester (between 20 and 26 weeks), the accuracy is +/- 2.1-2.5 weeks. … Most clinicians begin surveillance or induction at 41 weeks’ gestation.

43. Tool 7.3: Timeline for IHA EHR Transition | Digital Healthcare Research
    digital.ahrq.gov/health-it-tools-and-resources/implementation-toolsets-e-prescribing/toolset-e-prescribing/tool-73-timeline-iha-ehr-transition
    January 01, 2023 - Kickoff meeting: all office staff attending Perform pre-implementation assessment 6 Weeks … team resources to tasks as needed Develop new electronic workflows  Train superusers 2 Weeks … Go-Live   Trainer Train physicians Utilize training database (copied from live data every 2 weeks … ) 1-2 Weeks before Go-Live   Trainer or Implementation Manager (IM) Train staff

44. AHRQ's Safety Program for Nursing Homes: On-Time Pressure Ulcer Prevention | Agency for Healthcare Research and Quality
    www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/pruprev/exercises7.html
    December 01, 2017 - dash (-) is displayed None of the above If a weight was not obtained during one of the report weeks … signs: There is a slightly elevated temp with pulse and respiratory rate trending up over the past 2 weeks … ADLs: It appears the resident is trending toward increased dependence, especially in the last 2 weeks … Questions for the nursing assistant : This resident seems to be declining in certain ADLs for several weeks … Can you explain the dramatic reduction in meal intake for lunch and dinner over the last 2 weeks?

45. A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
    June 01, 2016 - (measured by the Roland-Morris Disability Questionnaire [RMDQ]) and leg pain from baseline to 6 weeks … The sec- ondary outcomes were improvement in function and leg pain at 3 weeks; the pro- portions of … ) and with substantial clinically meaningful improvement (≥50%) in disability and leg pain at 6 weeks … ; and scores at 3 and 6 weeks on six other measures of symptoms, func- tion, and satisfaction. … KEY FINDINGS »» At 6 weeks after injection, patients in both the glucocorticoids-plus-lidocaine group

46. NICU Family Information Packet, Appendix B, Breast Milk (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/nicu_toolkit/nicupacket-apb-breastmilk.pdf
    June 02, 2025 - iron, anti-infective properties (e.g., IgA), and neuroprotective properties for approximately 4-6 weeks … ■ Infants <34 weeks or BW<1800g should receive a multivitamin (1mL/day) and an iron supplement (2 … – Evaluate at 2-4 weeks post-discharge and as needed thereafter: weight, length, FOC, serum phosphorous

47. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks

48. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
    December 01, 2015 - (12 weeks of pegylated interferon alfa-2a, ribavirin, and telaprevir followed by 12 weeks of pegylated … telaprevir for 24 weeks (12 weeks of triple therapy followed by 12 weeks of dual therapy) … (Group A) to triple therapy with PEG-IFNα/RBV for 4 weeks followed by PEG-IFNα/RBV for 44 weeks with … telaprevir for 24 weeks (12 weeks of triple therapy followed by 12 weeks of dual therapy) … (Group A) to triple therapy with PEG- IFNα/RBV for 4 weeks followed by PEG- IFNα/RBV for 44 weeks

49. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c_surveillance.pdf
    December 01, 2015 - (12 weeks of pegylated interferon alfa-2a, ribavirin, and telaprevir followed by 12 weeks of pegylated … telaprevir for 24 weeks (12 weeks of triple therapy followed by 12 weeks of dual therapy) … (Group A) to triple therapy with PEG-IFNα/RBV for 4 weeks followed by PEG-IFNα/RBV for 44 weeks with … telaprevir for 24 weeks (12 weeks of triple therapy followed by 12 weeks of dual therapy) … (Group A) to triple therapy with PEG- IFNα/RBV for 4 weeks followed by PEG- IFNα/RBV for 44 weeks

50. Clinical Topic (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082textdesc.pdf
    January 01, 2012 - who gave birth during a 12-month period to a live singleton in vertex presentation at or beyond 37 weeks … who gave birth during a 12-month period to a live singleton in vertex presentation at or beyond 37 weeks … starts before or during [Attribute, stop datetime: Date of Delivery] <= 44 weeks starts before … who gave birth during a 12-month period to a live singleton in vertex presentation at or beyond 37 weeks … who gave birth during a 12-month period to a live singleton in vertex presentation at or beyond 37 weeks

51. 139. Treatment Recommendations: Medications-Nicotine Lozenge (continue | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide139.html
    October 01, 2014 - Generally, patients should use one lozenge every 1-2 hours during the first six weeks of treatment, using … a minimum of 9 lozenges/day, then decrease lozenge use to one lozenge every 2-4 hours during Weeks 7 … -9, and then to one lozenge every 4-8 hours for Weeks 10-12.  

52. 146. Treatment Recommendations: Medications-Nicotine Patch (continued) | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide146.html
    October 01, 2014 - Availability OTC or prescription Type Duration Dosage Step-Down Dosage 4 weeks … 21 mg/24 hours Step-Down Dosage then 2 weeks 14 mg/24 hours Step-Down Dosage then 2 … weeks 7 mg/24 hours Single Dosage Both a 22 mg/24 hours and an 11 mg/24 hours (for lighter

53. 132. Treatment Recommendations: Medications-Nicotine Gum | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide132.html
    October 01, 2014 - used with caution among particular cardiovascular patient groups: those in the immediate (within 2 weeks … Smokers should use at least 1 piece every 1 to 2 hours for the first six weeks and the gum should be … used for up to 12 weeks with no more than 24 pieces/day.

54. Archived: Gestational Diabetes Mellitus, Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/gestational-diabetes-mellitus-screening-january-2014
    January 14, 2014 - of gestation Asymptomatic pregnant women before 24 weeks of gestation Recommendation Screen … In the 2-step approach, the 50-g oral glucose challenge test is administered between 24 and 28 weeks … Screening before 24 weeks may identify women with glucose intolerance earlier in pregnancy. … Timing of Screening Screening is recommended after 24 weeks of gestation. … evidence about the benefits and harms of screening before 24 weeks of gestation.

55. National Prevention Week is May 12-18 | The Academy
    integrationacademy.ahrq.gov/news-and-events/news/national-prevention-week-may-12-18
    May 10, 2024 - An official website of the Department of Health & Human Services Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates The Academy Integrating Behavioral Health & Primary Care Expand Navi…

56. 138. Treatment Recommendations: Medications-Nicotine Lozenge | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/tobacco/clinicians/presentations/2008update-full/slide138.html
    October 01, 2014 - used with caution among particular cardiovascular patient groups: those in the immediate (within 2 weeks … Generally, smokers should use at least 9 lozenges per day in the first six weeks. … The lozenge should be used for up to 12 weeks with no more than 20 lozenges/day.

57. CER 215 Executive Summary: Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - Comparison/ Study design Acute Phase (< 12 weeks) (SOE) Continuation Phase (12 weeks to 48 weeks … ) (SOE) Continuation Phase (12 weeks to 48 weeks) (SOE) Maintenance Phase (>48 weeks) (SOE) SNRI … ) (SOE) Continuation Phase (12 weeks to 48 weeks) (SOE) Maintenance Phase (>48 weeks) (SOE) Mirtazapine … ) (SOE) Continuation Phase (12 weeks to 48 weeks) (SOE) Maintenance Phase (>48 weeks) (SOE) SSRI … ), but others evaluated only the continuation (12 weeks up to 48 weeks) or maintenance (beyond 48 weeks

58. Patient Safety Awareness Week. | PSNet
    psnet.ahrq.gov/issue/patient-safety-awareness-week
    July 12, 2017 - Webinar Patient Safety Awareness Week. Citation Text: Patient Safety Awareness Week. Institute for Healthcare Improvement. Copy Citation Save Save to your library Print Download PDF Share Facebook Twitter Linkedin Copy URL …

59. Final Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
    September 02, 2021 - hypertensive disorders of pregnancy over the course of pregnancy and in the postpartum period (up to 8 weeks … consequences from complications of pregnancy Maternal mortality Fetal/infant Preterm birth (<37 weeks … ): late preterm birth (34–36 weeks), moderate preterm birth, (32–34 weeks), very preterm birth (<32 weeks … ), extremely preterm birth (<28 weeks) Gestational age at birth Low birth weight (weight <2,500 g

60. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks … of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks